Docusign (NASDAQ:DOCU) Insider James Shaughnessy Sells 7,500 Shares

Key Points

• James Shaughnessy, an insider at Docusign, sold 7,500 shares of the company's stock for a total of $533,925, reducing his stake by 11.92%.
• Following the sale, Docusign shares fell by 1.3%, closing at $68.10, with a total trading volume of nearly 4.8 million shares.
• Docusign recently reported earnings per share of $0.92, surpassing analyst expectations, and has initiated a $1 billion stock buyback program signaling confidence in its valuation.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) insider James Shaughnessy sold 7,500 shares of the company's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total transaction of $533,925.00. Following the completion of the sale, the insider directly owned 55,442 shares of the company's stock, valued at $3,946,915.98. The trade was a 11.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Docusign Trading Down 1.3%

Shares of DOCU stock traded down $0.87 during trading hours on Thursday, hitting $68.10. 4,797,959 shares of the company were exchanged, compared to its average volume of 2,766,788. The business has a 50 day moving average of $76.62 and a two-hundred day moving average of $79.30. Docusign Inc. has a 52 week low of $61.91 and a 52 week high of $107.86. The company has a market capitalization of $13.69 billion, a PE ratio of 51.20, a PEG ratio of 3.58 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. During the same quarter in the prior year, the firm earned $0.97 earnings per share. The firm's revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, research analysts forecast that Docusign Inc. will post 1.17 EPS for the current year.

Docusign announced that its Board of Directors has initiated a stock buyback program on Thursday, June 5th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to buy up to 6.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Zacks Research raised shares of Docusign from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, September 9th. UBS Group set a $95.00 price objective on shares of Docusign in a research report on Friday, September 5th. Morgan Stanley increased their price objective on shares of Docusign from $86.00 to $90.00 and gave the stock an "equal weight" rating in a research report on Monday, September 8th. Evercore ISI raised their target price on shares of Docusign from $90.00 to $92.00 and gave the company an "in-line" rating in a research report on Friday, September 5th. Finally, Bank of America raised their target price on shares of Docusign from $85.00 to $102.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have assigned a Hold rating to the company. According to MarketBeat, Docusign presently has an average rating of "Hold" and an average price target of $94.14.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. State Street Corp lifted its stake in Docusign by 3.0% in the second quarter. State Street Corp now owns 8,074,976 shares of the company's stock valued at $628,960,000 after acquiring an additional 236,494 shares during the last quarter. American Century Companies Inc. lifted its stake in Docusign by 1.6% in the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company's stock valued at $433,405,000 after acquiring an additional 86,560 shares during the last quarter. Geode Capital Management LLC lifted its stake in Docusign by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company's stock valued at $309,910,000 after acquiring an additional 59,941 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Docusign by 18.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company's stock valued at $165,120,000 after acquiring an additional 318,698 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after acquiring an additional 1,440,269 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.